The International Society of Aesthetic Plastic Surgery (ISAPS) appoints Bahman Guyuron, MD, the editor-in-chief of Aesthetic Plastic Surgery, its official journal.
Aesthetic Plastic Surgery showcases the work of and provides a forum for the members of ISAPS, which according to a media release from the organization numbers more than 3,300 board-certified (or the equivalent) plastic surgeons in 104 countries.
Guyuron, who specializes in craniofacial plastic surgery, is considered a leading authority on migraine surgery and pioneered a method using nerve decompression, which eliminates trigger points from being targeted.
During his career, Guyuron—listed among the Best Doctors in America from 2000 to the present—has published more than 200 medical articles in peer-reviewed journals, as well as three textbooks and more than 40 book chapters on plastic surgery. He has delivered more than 1,000 lectures in more than 20 countries. Also, he has served as scientific reviewer and senior editor on a number of scientific journals, including Plastic and Reconstructive Surgery and Aesthetic Plastic Surgery, per the release.
Guyuron graduated from Tehran University Medical School in 1971, completed his residency in general surgery at Boston University on 1978, and received training in plastic surgery at the Cleveland Clinic Foundation. From 1980-1981, he did a specialized fellowship in craniofacial surgery at Toronto University’s Hospital for Sick Children.
He currently serves as Emeritus Professor of Plastic Surgery at Case Western Reserve University in Cleveland, his hometown.
“To assign this important role to such a distinguished plastic surgeon is an honor,” notes Susumu Takayanagi, MD, ISAPS president, in the release. “As champions of advancements in the field of plastic surgery worldwide, the ISAPS journal editor must take seriously all contributions submitted.”
“I look forward to working with an innovative professional who treats patient care as highly as research and application. Dr Guyuron is at the top of his field and brings a true specialty to our organization,” states incoming ISAPS president Dr Renato Saltz, per the release.
Guyuron will be formally introduced at the biennial ISAPS global Congress, which will take place October 23 to 27 in Kyoto, Japan.
[Source(s): Nasdaq GlobeNewswire, ISAPS]